Dangerous goods in DCTs: Key takeaways from a real-world direct-to-patient experience
While the direct-to-patient (DtP) model offers compelling advantages in clinical trials, there are still logistical complexities to work through. As one sponsor discovered recently, the shipment of dangerous goods is one of them.
